Volume: 57 - Issue: 5
First page: 331 - Last page: 335
B. Pugin - L. Deneyer - C. Bachert - I. Alobid - J. Bousquet - G. De Carlo - W.J. Fokkens - S. Gane - C. Hopkins - C. Holzmeister - C. Langdon - E.S. Lourijsen - V.J. Lund - G. Marien - M. Mavris - J. Mullol - C. Pereira-Perez - P.V. Tomazic - O. Vanderveken - P.W. Hellings - S.F. Seys
DOI: 10.4193/Rhin19.012
Despite the high prevalence of chronic rhinosinusitis (CRS) and its impact on patients’ quality of life, no European patient organization that advocates for patients with CRS currently exists. To fill this gap and give a voice to CRS patients, EUFOREA has created a patient advisory board, whose goal is to better understand the real-life needs of patients, to raise awareness at political level and to involve patients in the development of novel integrated solutions to accelerate access to accurate diagnosis and treatments. This report summarizes the key discussion points from the kick-off meeting of the board on the 8th June 2018 and provides an outline of the key objectives for the future.
Rhinology 57-5: 331-335, 2019
To see the issue content and the abstract you do not have to login
Please login to download the full articles
If you do not have a subscription to Rhinology please consider taking one.